MedPath

Biosimilar Collaborations Ireland Ltd.

🇮🇪Ireland
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

8

EMA:8

Drug Approvals

Yesintek

Authorization Status
Authorised
Approval Date
Feb 14, 2025
EMA

Yesafili

Authorization Status
Authorised
Approval Date
Sep 15, 2023
EMA

Abevmy

Authorization Status
Authorised
Approval Date
Apr 21, 2021
EMA

Kirsty (previously Kixelle)

Authorization Status
Authorised
Approval Date
Feb 5, 2021
EMA

Nepexto

Authorization Status
Authorised
Approval Date
May 20, 2020
EMA

Ogivri

Authorization Status
Authorised
Approval Date
Dec 12, 2018
EMA

Hulio

Authorization Status
Authorised
Approval Date
Sep 17, 2018
EMA

Semglee

Authorization Status
Authorised
Approval Date
Mar 23, 2018
EMA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.